Earnings Call · Q2 FY2023·2023-02-21

Q2 23EPS -100.00%*·Rev n/aQ1 23EPS +66.67%·Rev n/aQ4 22EPS -32.43%·Rev n/aQ3 22EPS -100.00%*·Rev n/a⚠ consensus missing

AYTU BIOPHARMA, INC AYTU

Roger Weiss — Host

Josh Disbrow — Chief Executive Officer

Mark Oki — Chief Financial Officer

−5.8%1d on move date−5.6% vs SPY3d−10.5%5d−9.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AYTU calls or request research access.

More AYTU calls Browse calls Request research access